|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Iowa Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing IowaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cellular Engineering Technologies
| | | Phone: | (319) 665-3000 | Fax: | (319) 665-3003 | Year Established: | 2000 | Main Contact: | Alan Moy, President & Co-Founder | | Company Description | Cellular Engineering Technologies (CET) specializes in stem cell research, tissue engineering and cancer biology. They develop media, provide and conduct research on stem cells obtained from human non-embryonic sources, such as adipose tissue, bone marrow, Wharton’s jelly, umbilical cord blood, and placentas. In addition, CET's mission is to be a leading provider of induced pluripotent (IPS) stem cells derived from normal human volunteers and patients with various clinical conditions. The company's engineering focus is on preclinical drug discovery and high throughput drug screening and discovery applications for various human diseases. CET's cancer biology focus is on the isolation and culture of solid tumors from cancers of the breast, colon, kidney, lung and prostate. | |
|
|
|
|
|